Effects of 5-fluorouracil derivative UFT on thymidylate synthetase and thymidine kinase in rat colorectal tumors

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 245-250

  Sakamoto, Shinobu ^a,b   Kawachi, Yasuyuki ^a   Iwama, Takeo ^a   Kuwa, Katsuhiko ^a   Suzuki, Toshie ^a   Mitamura, Tadasu ^a   Kudo, Hideki ^a   Sassa, Shuji ^a   Yoshimura, Shintarou ^a   Maemura, Tadatoshi ^a   Nakayama, Tohru ^a   Ohsawa, Mai ^a   Hara, Yukichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Histological differentiation; Rat colorectal tumors; Thymidine kinase; Thymidylate synthetase

Indexed keywords

1,2 DIMETHYLHYDRAZINE; FLUOROURACIL; PYRIMIDINE ANTAGONIST; THYMIDINE KINASE; THYMIDYLATE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; MALE; RATS; RNA, MESSENGER; TEGAFUR; THYMIDINE KINASE; THYMIDYLATE SYNTHASE; URACIL;

EID: 0032897374     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Heidelberger C, Duschinsky R: Fluorinated pyrimidine: a new class of tumor-inhibitory compounds. Nature 179: 663-666, 1957.
2. Leyva A, Van Groeningen CJ, Kraal I, Gall H, Peters GJ, Lankelma J, and Pinedo HM: Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Cancer Res 44: 5928-5933, 1984.
3. Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke J-M, Misset J-L, Schwarzenberg L, Fourtillan JB, Gaget H and Mathe G: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4: 685-696, 1986.
4. Fujii S, Ikenaka K, Fukushima M and Shirasaka T: Effects of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 69: 763-772, 1978.
5. Malik STA, Talbot D, Clarke PI, Osborne R, Reznek R, Wringley PFM and Slevin ML: Phase II trial of UFT in advanced colorectal and gastric cancer. Br J Cancer 62: 1023-1025, 1990.
6. Maehara Y, Kusumoto T, Kusumoto H, Anai H, Sakaguchi Y, Kido Y, Okamura T, Korenaga D and Sugimachi K: 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthetase. Cancer 63: 1593-1696, 1989.
7. Kawata S, Minami S, Tarui S, Marunaka T, Okamoto M and Yamano T: Cytochrome P-450-dependent oxidative cleavage of 1-(tetrahydro-2-furanyl)-5-fluorouracil to 5-fluorouracil. Jpn J Pharmacol 36: 43-49, 1984.
8. Boarman DM and Allegra CJ: Intracellular metabolism of 5-formyl tetrahydrofolate in human breast and colon cell lines. CancerRes 52: 36-44, 1992.
9. Sneider TW, Potter VR and Morris HP: Enzymes of thymidine triphosphate synthesis in selected Morris hepatomas. Cancer Res 29: 40-54, 1969.
10. Herzfeld A, Legg MA and Greengard O: Human colon tumors: Enzymic and histological characteristics. Cancer 42: 1280-1283, 1978.
11. Weber G, Lui MS, Takeda E and Denlon JE: Enzymology of human colon tumor. Life Sci 27: 793-799, 1980.
12. Marunaka T, Umeno Y, Yoshida K, Nagamachi M, Minami Y and Fujii S: High-pressure liquid Chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometricdetermination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur. J Pharmaceutical Sci 69: 209-213, 1980.
13. Morson BC: Histological grading of colorectal carcinoma. In: Color atlas of gastrointestinal pathology (Curran RC. ed). Oxford University Press: 1988, pp 245-248.
14. O'Driscoll L, Kennedy S, McDermott E, Keleham P and Clynes M: Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue. Eur JCancer 324: 128-133, 1996.
15. Sakamoto S, Hara Y, Mitamura T, Sassa S, Kudo H, Suzuki S, Kuwa K, Okayasu I and Shinoda H: Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Anti-Cancer Drugs 9: 351-357, 1998.
16. Sakamoto S, Kuwa K, Tsukada K, Sagara T, Kasahara N and Okamoto R: Relative activities of thyminidylate synthetase and thymidine kinase in 1,2-dimethylhydrazine-induced colon carcinomas in rats. Carcinogenesis 8: 405-408, 1987.
17. Dunlap RB, Harding NGL and Huennekens FM: Thymidylate synthetase from amethopterin-resistant Lactobacillus casei. Biochemistry 10: 88-97, 1971.
18. Taylor AT, Stafford MA and Jones OW: Properties of thymidine kinase partially purified from human fetal and adult tissues. J Biol Chem 247: 1930-1935, 1972.
19. Spears CP, Gustavsson BG, Berne M, Frosing R, Bernstein L and Hays AA: Mechanism of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res 48: 5894-5900, 1988.
20. Naguib FNM, El Kouni AM and ChaS: Enzymes of uracil catabolism in normal and neoplastic human tissues. CancerRes 45: 5405-5412, 1985.
21. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Demard F and Milano G: Response to fluorouracil therapy in cancer patients: The role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13: 1663-1670, 1995.
22. Leichman L, Lenz HJ, Leichman CG, Groshen S, Danenberg K, Baranda J, Spears CP, Boswell W, Silberman H, Ortega A, Stain S, Beart R and Danenberg P: Quantitation of intratumoral thymidylate synthase expression predicts forresistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial. Eur J Cancer 31: 1306-1310, 1995.
23. Sakamoto S, Kawachi Y, Konishi T. Pathological features and pyrimidine nucleotide synthesis in human gastric carcinomas. Anticancer Res 13: 879-882, 1993.
24. Sunter JP, Appleton DR, Wright NA and Watson AJ: Pathological of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Arch B Cell Pathol 29: 211-223, 1978.
25. Lasserre C, Sabatier L, Beaumatin J, Luccioni C, Lefrancois D, Muleris M and Dutrillaux B: Gene dosage and expression, and enzyme activity of thymidine kinase and thymidylate synthase in xenografted colorectal adenocarcinomas. Int J Cancer 56: 506-511, 1994.
26. Omura K, Kawakami K, Kanehira E, Nagasato A, Kawashima S, Tawaraya K, Watanabe S, Hirano K, Shirasaka T and Watanabe Y: The number of 5-fluoro-2'-deoxyuridine-5'-monophosphate binding sites and reduced folate poolin human colorectal carcinoma tissues: Changes after tegafur and uracil treatment. Cancer Res 55: 3897-3901, 1995.